Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Benjamin Bitler

Concepts (418)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
52
2026
599
13.910
Why?
Poly(ADP-ribose) Polymerase Inhibitors
16
2026
137
5.490
Why?
Cystadenocarcinoma, Serous
9
2026
90
3.990
Why?
Claudin-4
5
2025
18
2.920
Why?
Genomic Instability
3
2025
68
2.480
Why?
Drug Resistance, Neoplasm
14
2026
889
2.470
Why?
Cell Line, Tumor
45
2026
3565
2.410
Why?
Phthalazines
6
2026
63
2.380
Why?
Histone-Lysine N-Methyltransferase
4
2024
141
2.150
Why?
Tumor Microenvironment
14
2026
748
2.080
Why?
Piperazines
6
2026
375
2.060
Why?
Fallopian Tubes
3
2024
33
1.630
Why?
Xenograft Model Antitumor Assays
11
2026
939
1.570
Why?
Gene Expression Regulation, Neoplastic
23
2026
1457
1.520
Why?
Nuclear Proteins
10
2018
745
1.450
Why?
Transcription Factors
13
2023
1747
1.360
Why?
Polycomb Repressive Complex 1
4
2026
66
1.220
Why?
Cellular Senescence
8
2026
229
1.150
Why?
Antineoplastic Agents
8
2026
2231
1.060
Why?
Poly(ADP-ribose) Polymerases
4
2026
88
1.040
Why?
beta Catenin
4
2025
254
1.020
Why?
Cell Proliferation
13
2026
2529
0.990
Why?
Mice
36
2026
18493
0.970
Why?
Tumor Escape
2
2025
50
0.930
Why?
Female
69
2026
80081
0.910
Why?
Immune Evasion
1
2025
63
0.880
Why?
BRCA2 Protein
5
2024
68
0.870
Why?
Tryptophan Oxygenase
2
2024
33
0.860
Why?
Autophagy
2
2024
291
0.860
Why?
Animals
49
2026
38417
0.820
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2025
2001
0.790
Why?
Histocompatibility Antigens
2
2024
102
0.790
Why?
Neoplasms
6
2023
2946
0.750
Why?
Mucin-1
4
2012
29
0.750
Why?
Humans
85
2026
147306
0.740
Why?
Wnt Signaling Pathway
5
2025
212
0.730
Why?
Ovary
2
2022
236
0.730
Why?
Indoles
4
2025
510
0.710
Why?
Protein-Arginine N-Methyltransferases
2
2019
25
0.700
Why?
DNA-Binding Proteins
9
2020
1488
0.690
Why?
Neoplasms, Cystic, Mucinous, and Serous
2
2021
27
0.690
Why?
Breast Neoplasms
6
2024
2420
0.680
Why?
Mutation
11
2026
4130
0.680
Why?
Neoplasms, Glandular and Epithelial
4
2018
52
0.670
Why?
Ascites
1
2021
48
0.650
Why?
Up-Regulation
5
2020
848
0.640
Why?
Programmed Cell Death 1 Receptor
1
2022
268
0.640
Why?
ErbB Receptors
5
2024
638
0.640
Why?
DNA Repair
5
2026
256
0.630
Why?
Genomics
2
2024
839
0.620
Why?
Epoxy Compounds
1
2020
31
0.620
Why?
Cytoreduction Surgical Procedures
1
2020
69
0.610
Why?
Endometrial Neoplasms
4
2025
205
0.610
Why?
Carnitine O-Palmitoyltransferase
1
2020
49
0.610
Why?
Rad51 Recombinase
1
2019
15
0.610
Why?
Azepines
4
2026
105
0.590
Why?
Chemotherapy, Adjuvant
1
2020
429
0.570
Why?
Metabolomics
1
2024
737
0.570
Why?
CD8-Positive T-Lymphocytes
1
2024
933
0.550
Why?
Signal Transduction
10
2024
5272
0.540
Why?
Proteomics
1
2024
1205
0.520
Why?
Polycomb Repressive Complex 2
3
2015
79
0.510
Why?
Membrane Proteins
4
2019
1171
0.510
Why?
Neoadjuvant Therapy
1
2020
474
0.510
Why?
Pyridones
2
2018
210
0.500
Why?
Poly (ADP-Ribose) Polymerase-1
3
2026
55
0.500
Why?
Histones
4
2026
672
0.490
Why?
Disease Progression
10
2026
2892
0.490
Why?
Fatty Acids
1
2020
461
0.490
Why?
Wnt Proteins
2
2021
133
0.470
Why?
Biomarkers, Tumor
6
2025
1339
0.470
Why?
Tumor Suppressor Protein p53
5
2026
536
0.460
Why?
Enhancer of Zeste Homolog 2 Protein
6
2020
55
0.460
Why?
Cell Nucleus
3
2025
589
0.460
Why?
Histone Deacetylases
1
2017
208
0.460
Why?
DNA Breaks, Double-Stranded
2
2026
55
0.440
Why?
B7-H1 Antigen
3
2024
246
0.430
Why?
Methyltransferases
1
2015
75
0.420
Why?
Cell Survival
4
2026
1111
0.410
Why?
Protein Kinase Inhibitors
2
2026
984
0.390
Why?
Molecular Targeted Therapy
2
2021
444
0.390
Why?
Anoikis
3
2023
31
0.390
Why?
Tryptophan
2
2024
183
0.370
Why?
Peptides
3
2023
1003
0.370
Why?
Biological Assay
1
2013
134
0.370
Why?
Proto-Oncogene Proteins c-akt
1
2015
440
0.370
Why?
Small Molecule Libraries
1
2013
113
0.350
Why?
Gene Expression Profiling
6
2023
1794
0.340
Why?
Triazoles
3
2017
191
0.340
Why?
Carcinogenesis
3
2024
230
0.330
Why?
Apoptosis
6
2024
2454
0.310
Why?
Cells
1
2010
25
0.310
Why?
Mice, Transgenic
6
2024
2197
0.310
Why?
Inflammation
2
2023
2921
0.300
Why?
Alternative Splicing
2
2024
248
0.300
Why?
Neoplasm Invasiveness
2
2024
512
0.300
Why?
Neoplasm Grading
5
2024
313
0.300
Why?
Cisplatin
3
2026
347
0.280
Why?
DNA End-Joining Repair
2
2026
22
0.280
Why?
DNA Damage
5
2026
440
0.280
Why?
Transcriptome
3
2024
1059
0.280
Why?
Neoplasm Recurrence, Local
3
2025
1166
0.280
Why?
BRCA1 Protein
3
2021
83
0.270
Why?
Carcinoma
1
2010
231
0.270
Why?
Proto-Oncogene Proteins
1
2011
627
0.270
Why?
RNA, Small Interfering
5
2020
643
0.260
Why?
Piperidines
2
2019
224
0.260
Why?
Fibroblasts
1
2013
1040
0.260
Why?
Drug Synergism
2
2025
355
0.250
Why?
E1A-Associated p300 Protein
1
2026
15
0.240
Why?
Drug Delivery Systems
1
2010
381
0.240
Why?
Receptors, Interleukin-8B
1
2026
29
0.240
Why?
Ketoglutaric Acids
1
2026
22
0.240
Why?
Aurora Kinase A
1
2026
61
0.240
Why?
Peptide Fragments
1
2010
698
0.240
Why?
Histone Deacetylase Inhibitors
2
2018
219
0.230
Why?
Carnitine
1
2026
91
0.230
Why?
Oncogenes
2
2019
118
0.230
Why?
Imidazoles
2
2024
247
0.220
Why?
Cell Cycle
3
2025
600
0.220
Why?
Receptor, Interferon alpha-beta
1
2024
35
0.210
Why?
Micronuclei, Chromosome-Defective
1
2024
8
0.210
Why?
Prognosis
3
2024
4384
0.210
Why?
Amino Acid Transport System ASC
1
2024
12
0.210
Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
1
2024
56
0.210
Why?
Estrogen Receptor alpha
1
2026
154
0.210
Why?
Minor Histocompatibility Antigens
1
2024
47
0.210
Why?
Ligands
2
2024
675
0.200
Why?
Cytotoxicity, Immunologic
1
2024
224
0.200
Why?
Endogenous Retroviruses
1
2024
37
0.200
Why?
DNA Transposable Elements
1
2024
125
0.200
Why?
Wnt4 Protein
2
2024
20
0.200
Why?
Repressor Proteins
2
2018
429
0.200
Why?
Lysine
2
2023
305
0.200
Why?
Aldehyde Dehydrogenase
2
2016
99
0.200
Why?
Exons
1
2024
365
0.200
Why?
Chromatin
3
2025
561
0.190
Why?
Polycomb-Group Proteins
1
2023
36
0.190
Why?
Lymphocytes, Tumor-Infiltrating
2
2021
156
0.190
Why?
Kynurenine
1
2024
114
0.190
Why?
Activating Transcription Factor 6
1
2023
19
0.190
Why?
Retinoblastoma-Binding Protein 2
1
2022
4
0.190
Why?
Cell Movement
3
2018
966
0.180
Why?
Transcription Factor AP-1
1
2023
79
0.180
Why?
Pyrimidines
1
2026
532
0.180
Why?
Indazoles
2
2021
86
0.180
Why?
Cell Cycle Checkpoints
4
2019
97
0.180
Why?
Down-Regulation
4
2022
618
0.180
Why?
X-ray Repair Cross Complementing Protein 1
1
2022
14
0.180
Why?
Genital Neoplasms, Female
1
2024
100
0.180
Why?
Acetylation
2
2026
262
0.180
Why?
Tumor Cells, Cultured
3
2019
891
0.180
Why?
Tripartite Motif-Containing Protein 28
1
2021
15
0.170
Why?
Carcinoma, Endometrioid
1
2022
49
0.170
Why?
Triple Negative Breast Neoplasms
1
2024
220
0.170
Why?
Granulosa Cells
1
2021
37
0.170
Why?
Antigen Presentation
1
2022
209
0.170
Why?
Single-Cell Analysis
1
2024
367
0.170
Why?
Killer Cells, Natural
1
2024
481
0.170
Why?
RNA Interference
3
2019
477
0.170
Why?
Transfection
3
2021
930
0.170
Why?
Epigenomics
1
2021
125
0.170
Why?
Promoter Regions, Genetic
3
2017
1253
0.160
Why?
Ovarian Follicle
1
2021
78
0.160
Why?
Proteins
2
2017
1024
0.160
Why?
Gene Knockdown Techniques
2
2020
334
0.160
Why?
Vascular Endothelial Growth Factor Receptor-2
1
2021
87
0.160
Why?
Enzyme Inhibitors
1
2024
822
0.160
Why?
Cell Culture Techniques
2
2020
375
0.160
Why?
Macrophages
3
2024
1530
0.160
Why?
Immunity
2
2022
141
0.160
Why?
Lipids
1
2025
723
0.150
Why?
Early Detection of Cancer
1
2025
506
0.150
Why?
Wnt3A Protein
1
2019
11
0.150
Why?
Germ-Line Mutation
1
2021
180
0.150
Why?
Computational Biology
1
2024
677
0.150
Why?
Neoplasm Transplantation
2
2011
246
0.150
Why?
Interleukin-6
1
2024
784
0.150
Why?
Immunity, Innate
2
2024
840
0.150
Why?
Immunotherapy
2
2021
672
0.150
Why?
Transcription, Genetic
4
2024
1456
0.150
Why?
Acyltransferases
1
2019
78
0.150
Why?
Gene Frequency
1
2021
498
0.150
Why?
Machine Learning
1
2025
596
0.150
Why?
Receptors, Adiponectin
1
2019
23
0.150
Why?
Diagnostic Imaging
1
2022
342
0.150
Why?
Sequence Analysis, DNA
2
2021
780
0.150
Why?
Amino Acid Sequence
4
2015
2134
0.150
Why?
E2F Transcription Factors
1
2019
65
0.150
Why?
NF-kappa B
1
2023
676
0.140
Why?
Image Processing, Computer-Assisted
1
2023
794
0.140
Why?
Isocitrate Dehydrogenase
1
2019
72
0.140
Why?
CA-125 Antigen
1
2018
13
0.140
Why?
Heterografts
1
2019
143
0.140
Why?
Chloride Channels
1
2018
33
0.140
Why?
Protein Processing, Post-Translational
2
2021
482
0.140
Why?
Survival Rate
2
2020
2110
0.140
Why?
RNA Splicing Factors
1
2018
66
0.140
Why?
Drug Repositioning
1
2018
40
0.130
Why?
Chromosomal Proteins, Non-Histone
1
2018
130
0.130
Why?
Histone Deacetylase 6
1
2017
17
0.130
Why?
Mice, SCID
3
2018
369
0.130
Why?
Antineoplastic Agents, Phytogenic
1
2019
178
0.130
Why?
Genetic Testing
1
2021
493
0.130
Why?
Paclitaxel
1
2019
261
0.130
Why?
Cell Cycle Proteins
4
2017
633
0.130
Why?
Combined Modality Therapy
1
2020
1281
0.130
Why?
Claudins
1
2017
23
0.130
Why?
Sequence Analysis, RNA
1
2019
443
0.130
Why?
HMGB2 Protein
1
2016
4
0.120
Why?
Uterine Cervical Neoplasms
1
2020
268
0.120
Why?
Secretory Pathway
1
2016
8
0.120
Why?
Class I Phosphatidylinositol 3-Kinases
1
2017
108
0.120
Why?
Mevalonic Acid
1
2016
12
0.120
Why?
Adenocarcinoma, Clear Cell
1
2016
14
0.120
Why?
Tight Junctions
1
2017
87
0.120
Why?
Heterochromatin
2
2016
68
0.120
Why?
Mass Spectrometry
1
2019
728
0.120
Why?
RNA, Long Noncoding
1
2018
173
0.120
Why?
Mammary Glands, Animal
1
2017
128
0.120
Why?
Gene Expression Regulation, Enzymologic
1
2017
269
0.120
Why?
Genetics, Population
2
2008
226
0.120
Why?
Intracellular Signaling Peptides and Proteins
2
2019
459
0.120
Why?
Oxidation-Reduction
1
2020
1077
0.120
Why?
Mice, Nude
2
2015
680
0.120
Why?
Tumor Burden
1
2017
327
0.120
Why?
Colorectal Neoplasms
1
2024
877
0.120
Why?
Neoplasm Metastasis
4
2026
695
0.110
Why?
Endopeptidases
1
2015
80
0.110
Why?
Genetic Loci
1
2016
272
0.110
Why?
Phosphatidylinositol 3-Kinases
1
2017
383
0.110
Why?
Biomarkers
2
2024
4354
0.110
Why?
Protein Binding
3
2026
2249
0.110
Why?
Oxidative Stress
1
2021
1368
0.100
Why?
Homologous Recombination
2
2026
37
0.100
Why?
Disease Models, Animal
2
2024
4605
0.100
Why?
T-Lymphocytes
1
2022
2017
0.100
Why?
Epithelial Cells
2
2017
1141
0.100
Why?
Oncogene Protein p21(ras)
1
2013
15
0.100
Why?
Pyrimidine Nucleotides
1
2013
3
0.100
Why?
Purine Nucleotides
1
2013
12
0.100
Why?
beta-Galactosidase
1
2013
76
0.100
Why?
CCAAT-Binding Factor
1
2013
4
0.100
Why?
Carcinoma, Non-Small-Cell Lung
1
2022
1195
0.100
Why?
Dose-Response Relationship, Drug
1
2017
2030
0.090
Why?
Tomography, X-Ray Computed
1
2023
2791
0.090
Why?
Primary Cell Culture
1
2013
173
0.090
Why?
Genes, Reporter
1
2013
278
0.090
Why?
Aged, 80 and over
2
2025
8432
0.090
Why?
Proto-Oncogene Proteins c-met
1
2012
76
0.090
Why?
Gene Expression Regulation, Developmental
1
2017
915
0.090
Why?
Aged
5
2025
26516
0.090
Why?
RNA Helicases
1
2011
27
0.090
Why?
Mitosis
2
2026
194
0.090
Why?
Genes, ras
1
2011
96
0.090
Why?
Proteome
1
2016
520
0.090
Why?
Wnt-5a Protein
1
2011
25
0.090
Why?
Middle Aged
6
2025
36821
0.080
Why?
Interferons
2
2024
186
0.080
Why?
Molecular Sequence Data
3
2015
2886
0.080
Why?
Golgi Apparatus
1
2011
99
0.080
Why?
Gene Flow
2
2008
91
0.080
Why?
Follow-Up Studies
1
2020
5478
0.080
Why?
Cell Line
4
2021
2832
0.080
Why?
AMP-Activated Protein Kinases
2
2024
192
0.080
Why?
Models, Biological
3
2019
1772
0.080
Why?
Endosomes
1
2011
140
0.080
Why?
Gene Expression Regulation
3
2016
2625
0.080
Why?
Cyclin D1
1
2010
64
0.080
Why?
Active Transport, Cell Nucleus
1
2010
117
0.080
Why?
Cloning, Molecular
1
2010
539
0.070
Why?
Arachnida
1
2008
5
0.070
Why?
Caenorhabditis elegans Proteins
1
2011
209
0.070
Why?
Lung Neoplasms
1
2022
2679
0.070
Why?
Mammary Neoplasms, Experimental
1
2009
62
0.070
Why?
HEK293 Cells
2
2024
745
0.070
Why?
Prostatic Neoplasms
1
2015
986
0.070
Why?
Cytoplasm
1
2009
255
0.070
Why?
Immunohistochemistry
2
2022
1730
0.070
Why?
Trans-Activators
1
2010
398
0.060
Why?
Transforming Growth Factor alpha
1
2007
55
0.060
Why?
Mammary Neoplasms, Animal
1
2007
35
0.060
Why?
Neoplasm Staging
1
2011
1492
0.060
Why?
Bayes Theorem
2
2026
428
0.060
Why?
Cactaceae
1
2006
5
0.060
Why?
Triatoma
1
2006
7
0.060
Why?
Acetyl Coenzyme A
1
2026
8
0.060
Why?
Protein Structure, Tertiary
1
2009
855
0.060
Why?
Mice, Inbred NOD
2
2018
616
0.060
Why?
Mixed Function Oxygenases
1
2026
43
0.060
Why?
Dioxygenases
1
2026
36
0.060
Why?
Molecular Docking Simulation
1
2026
119
0.060
Why?
Phylogeny
2
2008
924
0.060
Why?
Phenylurea Compounds
1
2026
122
0.060
Why?
Fructose
1
2026
132
0.060
Why?
Acidosis
1
2026
107
0.060
Why?
Maintenance Chemotherapy
1
2025
42
0.060
Why?
Myeloid-Derived Suppressor Cells
1
2026
77
0.060
Why?
Drosophila
1
2006
168
0.060
Why?
Hydrogen-Ion Concentration
1
2026
536
0.050
Why?
Genetic Variation
2
2008
995
0.050
Why?
Evolution, Molecular
1
2008
502
0.050
Why?
Epigenesis, Genetic
2
2020
708
0.050
Why?
Retinal Dehydrogenase
2
2016
29
0.050
Why?
Protein Transport
2
2019
442
0.050
Why?
Antineoplastic Agents, Hormonal
1
2026
196
0.050
Why?
Carbonyl Reductase (NADPH)
1
2024
5
0.050
Why?
Mutation, Missense
1
2026
337
0.050
Why?
Signal-To-Noise Ratio
1
2023
73
0.050
Why?
Transcription Factor RelB
1
2023
3
0.050
Why?
Cytokine TWEAK
1
2023
2
0.050
Why?
Protein Isoforms
1
2024
398
0.050
Why?
Tumor Necrosis Factors
1
2023
10
0.050
Why?
TWEAK Receptor
1
2023
6
0.050
Why?
Enhancer Elements, Genetic
1
2024
191
0.050
Why?
Muscular Atrophy
1
2023
87
0.050
Why?
Artifacts
1
2023
144
0.050
Why?
Cachexia
1
2023
74
0.050
Why?
Recombinational DNA Repair
1
2022
19
0.050
Why?
Carboplatin
1
2023
168
0.050
Why?
Receptors, Tumor Necrosis Factor
1
2023
163
0.050
Why?
Oligonucleotide Array Sequence Analysis
2
2016
751
0.040
Why?
Estradiol
1
2026
515
0.040
Why?
Gene Regulatory Networks
1
2024
318
0.040
Why?
Eukaryotic Initiation Factor-2
1
2021
32
0.040
Why?
Heterocyclic Compounds, 3-Ring
1
2021
44
0.040
Why?
Open Reading Frames
1
2021
130
0.040
Why?
Cluster Analysis
1
2022
502
0.040
Why?
Neutrophils
1
2026
1135
0.040
Why?
Double-Blind Method
1
2025
2080
0.040
Why?
Cell Division
1
2021
758
0.040
Why?
Culture Media, Conditioned
1
2019
112
0.040
Why?
Disease Susceptibility
1
2021
347
0.040
Why?
Paracrine Communication
1
2019
67
0.040
Why?
Mice, Inbred C57BL
3
2018
6042
0.040
Why?
Chromatin Assembly and Disassembly
1
2020
109
0.040
Why?
Coculture Techniques
1
2019
247
0.040
Why?
Blotting, Western
2
2011
1186
0.040
Why?
Computer Simulation
1
2023
1018
0.040
Why?
Immunophenotyping
1
2020
325
0.040
Why?
DNA
1
2025
1444
0.030
Why?
Mechanistic Target of Rapamycin Complex 1
1
2019
138
0.030
Why?
Protein Biosynthesis
1
2021
452
0.030
Why?
Gene Amplification
1
2018
118
0.030
Why?
Stem Cells
1
2023
630
0.030
Why?
Flow Cytometry
1
2022
1172
0.030
Why?
Survival Analysis
1
2021
1386
0.030
Why?
Desert Climate
2
2008
15
0.030
Why?
Aniline Compounds
1
2018
120
0.030
Why?
Recurrence
1
2021
1151
0.030
Why?
Arizona
2
2008
81
0.030
Why?
Case-Control Studies
1
2025
3660
0.030
Why?
Receptors, G-Protein-Coupled
1
2019
232
0.030
Why?
DNA Helicases
1
2018
137
0.030
Why?
Mexico
2
2008
233
0.030
Why?
Phosphorylation
1
2021
1721
0.030
Why?
Disease Management
1
2021
654
0.030
Why?
Pyridines
1
2021
610
0.030
Why?
Epithelial-Mesenchymal Transition
1
2018
222
0.030
Why?
Tumor Necrosis Factor-alpha
1
2021
1225
0.030
Why?
DNA, Mitochondrial
2
2008
212
0.030
Why?
Gene Knockout Techniques
1
2016
122
0.030
Why?
Sumoylation
1
2015
17
0.030
Why?
Lactation
1
2017
195
0.030
Why?
Metabolic Networks and Pathways
1
2016
175
0.030
Why?
T-Lymphocytes, Cytotoxic
1
2016
180
0.030
Why?
Algorithms
1
2023
1868
0.030
Why?
Models, Genetic
2
2008
536
0.030
Why?
Proteolysis
1
2015
173
0.030
Why?
Gene Silencing
1
2015
203
0.030
Why?
Protein-Tyrosine Kinases
1
2017
432
0.030
Why?
Chromatography, Liquid
1
2016
453
0.030
Why?
Sulfonamides
1
2018
596
0.030
Why?
Mice, Inbred BALB C
1
2017
1266
0.030
Why?
E2F7 Transcription Factor
1
2013
1
0.020
Why?
Ribonucleoside Diphosphate Reductase
1
2013
6
0.020
Why?
Melanoma
1
2020
774
0.020
Why?
Nucleosides
1
2013
25
0.020
Why?
Muscle, Skeletal
1
2023
1798
0.020
Why?
Tandem Mass Spectrometry
1
2016
575
0.020
Why?
Cell Growth Processes
1
2013
48
0.020
Why?
Epidermal Growth Factor
1
2012
162
0.020
Why?
ras Proteins
1
2013
153
0.020
Why?
Fanconi Anemia Complementation Group Proteins
1
2011
7
0.020
Why?
Adult
2
2025
41406
0.020
Why?
Genes, BRCA1
1
2011
45
0.020
Why?
Sorting Nexins
1
2011
12
0.020
Why?
Chromatin Immunoprecipitation
1
2011
139
0.020
Why?
Two-Hybrid System Techniques
1
2011
59
0.020
Why?
Time Factors
2
2016
7173
0.020
Why?
Mice, Knockout
1
2018
3153
0.020
Why?
Immunoprecipitation
1
2011
149
0.020
Why?
Proto-Oncogene Proteins B-raf
1
2013
230
0.020
Why?
Real-Time Polymerase Chain Reaction
1
2011
337
0.020
Why?
Endocytosis
1
2011
168
0.020
Why?
Protein Folding
1
2011
280
0.020
Why?
HeLa Cells
1
2011
633
0.020
Why?
Cell Transformation, Neoplastic
1
2011
340
0.020
Why?
Recombinant Fusion Proteins
1
2011
669
0.020
Why?
Geography
1
2008
187
0.020
Why?
Phenotype
1
2016
3216
0.020
Why?
Population Dynamics
1
2008
143
0.020
Why?
Cells, Cultured
1
2015
4170
0.020
Why?
Caenorhabditis elegans
1
2011
330
0.020
Why?
Genes, Insect
1
2006
22
0.020
Why?
Haplotypes
1
2008
509
0.020
Why?
Cytochromes b
1
2006
12
0.020
Why?
Electron Transport Complex IV
1
2006
61
0.010
Why?
Insect Vectors
1
2006
39
0.010
Why?
Chagas Disease
1
2006
42
0.010
Why?
Host-Parasite Interactions
1
2006
110
0.010
Why?
Lymphoma
1
2007
253
0.010
Why?
Pregnancy
1
2017
7276
0.010
Why?
RNA, Messenger
1
2011
2812
0.010
Why?
Firefly Luciferin
1
1957
1
0.010
Why?
Diptera
1
1957
31
0.010
Why?
Luciferases
1
1957
155
0.010
Why?
Male
1
2015
73954
0.000
Why?
Bitler's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)